Global Bio-Therapeutic Glycoproteins Market Research Report 2023

Bio-Therapeutic Glycoproteins are bioactive compounds with carbohydrates attached to proteins. Glycan is the specific site where carbohydrate attaches to proteins and process of production is called glycosylation. Bio-therapeutic glycoproteins produced with glycan moieties that are similar to natural mammal glycans. The most common types are glycosylation O-linked and N-linked that are mainly depends on protein sequence attachment. Carbohydrates linked to proteins through either α and β linkages. Glycosylation is an important process of bio-therapeutic glycoproteins because it is critically modulated into bioactivity, stability, solubility against proteolysis, yield, clearance rate from circulation and immunogenicity. The bio-therapeutic glycoproteins mainly produced by yeast expression systems, insect cells, mammalian systems, and plant-based expression systems. In yeast expression systems, yeast is cultured chemically to scale up fermentation to an industrial level. Yeast and human share same N-glycan's linkage. Insect cells represent an alternative system for expression of recombinant bio-therapeutic proteins. Later recombinant proteins are separated from insect cells. Mammalian Systems are used to produce complex bio-therapeutic glycoproteins. Most of the FDA approved bio-therapeutic glycoproteins derived from mammalian systems. Plant-based expression systems used for the scale-up production of glycoproteins. Among all systems, mammalian systems are well established in pharmaceuticals. Some examples of bio-therapeutic glycoproteins include tocilizumab, bevacizumab, adalimumab, etc.

The global Bio-Therapeutic Glycoproteins market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

The potential benefits of Bio-Therapeutic Glycoproteins have been a subject of rising industrial interest in the context of wide range application. So, far they include several protein classes like antisera, cytokines, clotting factors, hormones, enzymes and enzyme inhibitors have been best suited physiologically. The trend of industrial developments likely continues alongside with growing knowledge about the functions of bio-therapeutic glycoproteins. Bio-Therapeutic Glycoproteins are a fastest growing field in the pharmaceutical industry due to a wide range of applicability. The mammalian expression system is used to produce glycoproteins that coded with human-like glycans. Bio-Therapeutic glycoproteins represent an integrated treatment for most of the autoimmune disorders, cancers, replacement therapies like hormone and enzyme substituted. All these benefits of glycoproteins drive the robust growth of the Bio-Therapeutic Glycoproteins market.

This report aims to provide a comprehensive presentation of the global market for Bio-Therapeutic Glycoproteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-Therapeutic Glycoproteins.

The Bio-Therapeutic Glycoproteins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bio-Therapeutic Glycoproteins market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bio-Therapeutic Glycoproteins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Bio-Therapeutic Glycoproteins

1.2 Bio-Therapeutic Glycoproteins Segment by Type

1.2.1 Global Bio-Therapeutic Glycoproteins Market Value Comparison by Type (2023-2029)

1.2.2 Antisera

1.2.3 Cytokines

1.2.4 Clotting Factors

1.2.5 Hormones

1.2.6 Enzymes

1.2.7 Enzyme Inhibitors

1.3 Bio-Therapeutic Glycoproteins Segment by Application

1.3.1 Global Bio-Therapeutic Glycoproteins Market Value by Application: (2023-2029)

1.3.2 Oncology and Haematology

1.3.3 Diabetes

1.3.4 Cardiology

1.3.5 Inflammatory Diseases

1.3.6 Others

1.4 Global Bio-Therapeutic Glycoproteins Market Size Estimates and Forecasts

1.4.1 Global Bio-Therapeutic Glycoproteins Revenue 2018-2029

1.4.2 Global Bio-Therapeutic Glycoproteins Sales 2018-2029

1.4.3 Global Bio-Therapeutic Glycoproteins Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Bio-Therapeutic Glycoproteins Sales Market Share by Manufacturers (2018-2023)

2.2 Global Bio-Therapeutic Glycoproteins Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Bio-Therapeutic Glycoproteins Average Price by Manufacturers (2018-2023)

2.4 Global Bio-Therapeutic Glycoproteins Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Bio-Therapeutic Glycoproteins, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Bio-Therapeutic Glycoproteins, Product Type & Application

2.7 Bio-Therapeutic Glycoproteins Market Competitive Situation and Trends

2.7.1 Bio-Therapeutic Glycoproteins Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Bio-Therapeutic Glycoproteins Players Market Share by Revenue

2.7.3 Global Bio-Therapeutic Glycoproteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Bio-Therapeutic Glycoproteins Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Bio-Therapeutic Glycoproteins Global Bio-Therapeutic Glycoproteins Sales by Region: 2018-2029

3.2.1 Global Bio-Therapeutic Glycoproteins Sales by Region: 2018-2023

3.2.2 Global Bio-Therapeutic Glycoproteins Sales by Region: 2024-2029

3.3 Global Bio-Therapeutic Glycoproteins Global Bio-Therapeutic Glycoproteins Revenue by Region: 2018-2029

3.3.1 Global Bio-Therapeutic Glycoproteins Revenue by Region: 2018-2023

3.3.2 Global Bio-Therapeutic Glycoproteins Revenue by Region: 2024-2029

3.4 North America Bio-Therapeutic Glycoproteins Market Facts & Figures by Country

3.4.1 North America Bio-Therapeutic Glycoproteins Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Bio-Therapeutic Glycoproteins Sales by Country (2018-2029)

3.4.3 North America Bio-Therapeutic Glycoproteins Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Bio-Therapeutic Glycoproteins Market Facts & Figures by Country

3.5.1 Europe Bio-Therapeutic Glycoproteins Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Bio-Therapeutic Glycoproteins Sales by Country (2018-2029)

3.5.3 Europe Bio-Therapeutic Glycoproteins Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Bio-Therapeutic Glycoproteins Market Facts & Figures by Country

3.6.1 Asia Pacific Bio-Therapeutic Glycoproteins Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Bio-Therapeutic Glycoproteins Sales by Country (2018-2029)

3.6.3 Asia Pacific Bio-Therapeutic Glycoproteins Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Bio-Therapeutic Glycoproteins Market Facts & Figures by Country

3.7.1 Latin America Bio-Therapeutic Glycoproteins Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Bio-Therapeutic Glycoproteins Sales by Country (2018-2029)

3.7.3 Latin America Bio-Therapeutic Glycoproteins Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Bio-Therapeutic Glycoproteins Market Facts & Figures by Country

3.8.1 Middle East and Africa Bio-Therapeutic Glycoproteins Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Bio-Therapeutic Glycoproteins Sales by Country (2018-2029)

3.8.3 Middle East and Africa Bio-Therapeutic Glycoproteins Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Bio-Therapeutic Glycoproteins Sales by Type (2018-2029)

4.1.1 Global Bio-Therapeutic Glycoproteins Sales by Type (2018-2023)

4.1.2 Global Bio-Therapeutic Glycoproteins Sales by Type (2024-2029)

4.1.3 Global Bio-Therapeutic Glycoproteins Sales Market Share by Type (2018-2029)

4.2 Global Bio-Therapeutic Glycoproteins Revenue by Type (2018-2029)

4.2.1 Global Bio-Therapeutic Glycoproteins Revenue by Type (2018-2023)

4.2.2 Global Bio-Therapeutic Glycoproteins Revenue by Type (2024-2029)

4.2.3 Global Bio-Therapeutic Glycoproteins Revenue Market Share by Type (2018-2029)

4.3 Global Bio-Therapeutic Glycoproteins Price by Type (2018-2029)

5.1 Global Bio-Therapeutic Glycoproteins Sales by Application (2018-2029)

5.1.1 Global Bio-Therapeutic Glycoproteins Sales by Application (2018-2023)

5.1.2 Global Bio-Therapeutic Glycoproteins Sales by Application (2024-2029)

5.1.3 Global Bio-Therapeutic Glycoproteins Sales Market Share by Application (2018-2029)

5.2 Global Bio-Therapeutic Glycoproteins Revenue by Application (2018-2029)

5.2.1 Global Bio-Therapeutic Glycoproteins Revenue by Application (2018-2023)

5.2.2 Global Bio-Therapeutic Glycoproteins Revenue by Application (2024-2029)

5.2.3 Global Bio-Therapeutic Glycoproteins Revenue Market Share by Application (2018-2029)

5.3 Global Bio-Therapeutic Glycoproteins Price by Application (2018-2029)

6.1 Genentech

6.1.1 Genentech Corporation Information

6.1.2 Genentech Description and Business Overview

6.1.3 Genentech Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Genentech Bio-Therapeutic Glycoproteins Product Portfolio

6.1.5 Genentech Recent Developments/Updates

6.2 Hoffmann-La Roche

6.2.1 Hoffmann-La Roche Corporation Information

6.2.2 Hoffmann-La Roche Description and Business Overview

6.2.3 Hoffmann-La Roche Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Hoffmann-La Roche Bio-Therapeutic Glycoproteins Product Portfolio

6.2.5 Hoffmann-La Roche Recent Developments/Updates

6.3 Genzyme Corp

6.3.1 Genzyme Corp Corporation Information

6.3.2 Genzyme Corp Description and Business Overview

6.3.3 Genzyme Corp Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Genzyme Corp Bio-Therapeutic Glycoproteins Product Portfolio

6.3.5 Genzyme Corp Recent Developments/Updates

6.4 Abbott Laboratories

6.4.1 Abbott Laboratories Corporation Information

6.4.2 Abbott Laboratories Description and Business Overview

6.4.3 Abbott Laboratories Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Abbott Laboratories Bio-Therapeutic Glycoproteins Product Portfolio

6.4.5 Abbott Laboratories Recent Developments/Updates

6.5 Amgen

6.5.1 Amgen Corporation Information

6.5.2 Amgen Description and Business Overview

6.5.3 Amgen Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Amgen Bio-Therapeutic Glycoproteins Product Portfolio

6.5.5 Amgen Recent Developments/Updates

6.6 Biogen

6.6.1 Biogen Corporation Information

6.6.2 Biogen Description and Business Overview

6.6.3 Biogen Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Biogen Bio-Therapeutic Glycoproteins Product Portfolio

6.6.5 Biogen Recent Developments/Updates

6.7 Merck

6.6.1 Merck Corporation Information

6.6.2 Merck Description and Business Overview

6.6.3 Merck Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Merck Bio-Therapeutic Glycoproteins Product Portfolio

6.7.5 Merck Recent Developments/Updates

6.8 GlaxoSmithKline

6.8.1 GlaxoSmithKline Corporation Information

6.8.2 GlaxoSmithKline Description and Business Overview

6.8.3 GlaxoSmithKline Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2018-2023)

6.8.4 GlaxoSmithKline Bio-Therapeutic Glycoproteins Product Portfolio

6.8.5 GlaxoSmithKline Recent Developments/Updates

6.9 Novartis Pharmaceuticals Corp

6.9.1 Novartis Pharmaceuticals Corp Corporation Information

6.9.2 Novartis Pharmaceuticals Corp Description and Business Overview

6.9.3 Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Product Portfolio

6.9.5 Novartis Pharmaceuticals Corp Recent Developments/Updates

7.1 Bio-Therapeutic Glycoproteins Industry Chain Analysis

7.2 Bio-Therapeutic Glycoproteins Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Bio-Therapeutic Glycoproteins Production Mode & Process

7.4 Bio-Therapeutic Glycoproteins Sales and Marketing

7.4.1 Bio-Therapeutic Glycoproteins Sales Channels

7.4.2 Bio-Therapeutic Glycoproteins Distributors

7.5 Bio-Therapeutic Glycoproteins Customers

8.1 Bio-Therapeutic Glycoproteins Industry Trends

8.2 Bio-Therapeutic Glycoproteins Market Drivers

8.3 Bio-Therapeutic Glycoproteins Market Challenges

8.4 Bio-Therapeutic Glycoproteins Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Bio-Therapeutic Glycoproteins Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Bio-Therapeutic Glycoproteins Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Bio-Therapeutic Glycoproteins Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Bio-Therapeutic Glycoproteins Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Bio-Therapeutic Glycoproteins Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Bio-Therapeutic Glycoproteins Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Bio-Therapeutic Glycoproteins Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Bio-Therapeutic Glycoproteins Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Bio-Therapeutic Glycoproteins, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Bio-Therapeutic Glycoproteins, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Bio-Therapeutic Glycoproteins, Product Type & Application

    Table 12. Global Key Manufacturers of Bio-Therapeutic Glycoproteins, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Bio-Therapeutic Glycoproteins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-Therapeutic Glycoproteins as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Bio-Therapeutic Glycoproteins Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Bio-Therapeutic Glycoproteins Sales by Region (2018-2023) & (K Units)

    Table 18. Global Bio-Therapeutic Glycoproteins Sales Market Share by Region (2018-2023)

    Table 19. Global Bio-Therapeutic Glycoproteins Sales by Region (2024-2029) & (K Units)

    Table 20. Global Bio-Therapeutic Glycoproteins Sales Market Share by Region (2024-2029)

    Table 21. Global Bio-Therapeutic Glycoproteins Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Region (2018-2023)

    Table 23. Global Bio-Therapeutic Glycoproteins Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Region (2024-2029)

    Table 25. North America Bio-Therapeutic Glycoproteins Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Bio-Therapeutic Glycoproteins Sales by Country (2018-2023) & (K Units)

    Table 27. North America Bio-Therapeutic Glycoproteins Sales by Country (2024-2029) & (K Units)

    Table 28. North America Bio-Therapeutic Glycoproteins Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Bio-Therapeutic Glycoproteins Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Bio-Therapeutic Glycoproteins Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Bio-Therapeutic Glycoproteins Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Bio-Therapeutic Glycoproteins Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Bio-Therapeutic Glycoproteins Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Bio-Therapeutic Glycoproteins Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Bio-Therapeutic Glycoproteins Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Bio-Therapeutic Glycoproteins Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Bio-Therapeutic Glycoproteins Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Bio-Therapeutic Glycoproteins Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Bio-Therapeutic Glycoproteins Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Bio-Therapeutic Glycoproteins Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Bio-Therapeutic Glycoproteins Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Bio-Therapeutic Glycoproteins Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Bio-Therapeutic Glycoproteins Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Bio-Therapeutic Glycoproteins Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Bio-Therapeutic Glycoproteins Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Bio-Therapeutic Glycoproteins Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Bio-Therapeutic Glycoproteins Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Bio-Therapeutic Glycoproteins Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Bio-Therapeutic Glycoproteins Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Bio-Therapeutic Glycoproteins Sales (K Units) by Type (2018-2023)

    Table 51. Global Bio-Therapeutic Glycoproteins Sales (K Units) by Type (2024-2029)

    Table 52. Global Bio-Therapeutic Glycoproteins Sales Market Share by Type (2018-2023)

    Table 53. Global Bio-Therapeutic Glycoproteins Sales Market Share by Type (2024-2029)

    Table 54. Global Bio-Therapeutic Glycoproteins Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Bio-Therapeutic Glycoproteins Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Type (2018-2023)

    Table 57. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Type (2024-2029)

    Table 58. Global Bio-Therapeutic Glycoproteins Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Bio-Therapeutic Glycoproteins Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Bio-Therapeutic Glycoproteins Sales (K Units) by Application (2018-2023)

    Table 61. Global Bio-Therapeutic Glycoproteins Sales (K Units) by Application (2024-2029)

    Table 62. Global Bio-Therapeutic Glycoproteins Sales Market Share by Application (2018-2023)

    Table 63. Global Bio-Therapeutic Glycoproteins Sales Market Share by Application (2024-2029)

    Table 64. Global Bio-Therapeutic Glycoproteins Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Bio-Therapeutic Glycoproteins Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Application (2018-2023)

    Table 67. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Application (2024-2029)

    Table 68. Global Bio-Therapeutic Glycoproteins Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Bio-Therapeutic Glycoproteins Price (USD/Unit) by Application (2024-2029)

    Table 70. Genentech Corporation Information

    Table 71. Genentech Description and Business Overview

    Table 72. Genentech Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. Genentech Bio-Therapeutic Glycoproteins Product

    Table 74. Genentech Recent Developments/Updates

    Table 75. Hoffmann-La Roche Corporation Information

    Table 76. Hoffmann-La Roche Description and Business Overview

    Table 77. Hoffmann-La Roche Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Hoffmann-La Roche Bio-Therapeutic Glycoproteins Product

    Table 79. Hoffmann-La Roche Recent Developments/Updates

    Table 80. Genzyme Corp Corporation Information

    Table 81. Genzyme Corp Description and Business Overview

    Table 82. Genzyme Corp Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Genzyme Corp Bio-Therapeutic Glycoproteins Product

    Table 84. Genzyme Corp Recent Developments/Updates

    Table 85. Abbott Laboratories Corporation Information

    Table 86. Abbott Laboratories Description and Business Overview

    Table 87. Abbott Laboratories Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. Abbott Laboratories Bio-Therapeutic Glycoproteins Product

    Table 89. Abbott Laboratories Recent Developments/Updates

    Table 90. Amgen Corporation Information

    Table 91. Amgen Description and Business Overview

    Table 92. Amgen Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. Amgen Bio-Therapeutic Glycoproteins Product

    Table 94. Amgen Recent Developments/Updates

    Table 95. Biogen Corporation Information

    Table 96. Biogen Description and Business Overview

    Table 97. Biogen Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Biogen Bio-Therapeutic Glycoproteins Product

    Table 99. Biogen Recent Developments/Updates

    Table 100. Merck Corporation Information

    Table 101. Merck Description and Business Overview

    Table 102. Merck Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. Merck Bio-Therapeutic Glycoproteins Product

    Table 104. Merck Recent Developments/Updates

    Table 105. GlaxoSmithKline Corporation Information

    Table 106. GlaxoSmithKline Description and Business Overview

    Table 107. GlaxoSmithKline Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 108. GlaxoSmithKline Bio-Therapeutic Glycoproteins Product

    Table 109. GlaxoSmithKline Recent Developments/Updates

    Table 110. Novartis Pharmaceuticals Corp Corporation Information

    Table 111. Novartis Pharmaceuticals Corp Description and Business Overview

    Table 112. Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 113. Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Product

    Table 114. Novartis Pharmaceuticals Corp Recent Developments/Updates

    Table 115. Key Raw Materials Lists

    Table 116. Raw Materials Key Suppliers Lists

    Table 117. Bio-Therapeutic Glycoproteins Distributors List

    Table 118. Bio-Therapeutic Glycoproteins Customers List

    Table 119. Bio-Therapeutic Glycoproteins Market Trends

    Table 120. Bio-Therapeutic Glycoproteins Market Drivers

    Table 121. Bio-Therapeutic Glycoproteins Market Challenges

    Table 122. Bio-Therapeutic Glycoproteins Market Restraints

    Table 123. Research Programs/Design for This Report

    Table 124. Key Data Information from Secondary Sources

    Table 125. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Bio-Therapeutic Glycoproteins

    Figure 2. Global Bio-Therapeutic Glycoproteins Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Bio-Therapeutic Glycoproteins Market Share by Type in 2022 & 2029

    Figure 4. Antisera Product Picture

    Figure 5. Cytokines Product Picture

    Figure 6. Clotting Factors Product Picture

    Figure 7. Hormones Product Picture

    Figure 8. Enzymes Product Picture

    Figure 9. Enzyme Inhibitors Product Picture

    Figure 10. Global Bio-Therapeutic Glycoproteins Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 11. Global Bio-Therapeutic Glycoproteins Market Share by Application in 2022 & 2029

    Figure 12. Oncology and Haematology

    Figure 13. Diabetes

    Figure 14. Cardiology

    Figure 15. Inflammatory Diseases

    Figure 16. Others

    Figure 17. Global Bio-Therapeutic Glycoproteins Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Bio-Therapeutic Glycoproteins Market Size (2018-2029) & (US$ Million)

    Figure 19. Global Bio-Therapeutic Glycoproteins Sales (2018-2029) & (K Units)

    Figure 20. Global Bio-Therapeutic Glycoproteins Average Price (USD/Unit) & (2018-2029)

    Figure 21. Bio-Therapeutic Glycoproteins Report Years Considered

    Figure 22. Bio-Therapeutic Glycoproteins Sales Share by Manufacturers in 2022

    Figure 23. Global Bio-Therapeutic Glycoproteins Revenue Share by Manufacturers in 2022

    Figure 24. The Global 5 and 10 Largest Bio-Therapeutic Glycoproteins Players: Market Share by Revenue in 2022

    Figure 25. Bio-Therapeutic Glycoproteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 26. Global Bio-Therapeutic Glycoproteins Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 27. North America Bio-Therapeutic Glycoproteins Sales Market Share by Country (2018-2029)

    Figure 28. North America Bio-Therapeutic Glycoproteins Revenue Market Share by Country (2018-2029)

    Figure 29. U.S. Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Canada Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Europe Bio-Therapeutic Glycoproteins Sales Market Share by Country (2018-2029)

    Figure 32. Europe Bio-Therapeutic Glycoproteins Revenue Market Share by Country (2018-2029)

    Figure 33. Germany Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. France Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. U.K. Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Italy Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Russia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Asia Pacific Bio-Therapeutic Glycoproteins Sales Market Share by Region (2018-2029)

    Figure 39. Asia Pacific Bio-Therapeutic Glycoproteins Revenue Market Share by Region (2018-2029)

    Figure 40. China Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Japan Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. South Korea Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. India Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Australia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Taiwan Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Indonesia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Thailand Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Malaysia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Philippines Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Latin America Bio-Therapeutic Glycoproteins Sales Market Share by Country (2018-2029)

    Figure 51. Latin America Bio-Therapeutic Glycoproteins Revenue Market Share by Country (2018-2029)

    Figure 52. Mexico Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Brazil Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Argentina Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Middle East & Africa Bio-Therapeutic Glycoproteins Sales Market Share by Country (2018-2029)

    Figure 56. Middle East & Africa Bio-Therapeutic Glycoproteins Revenue Market Share by Country (2018-2029)

    Figure 57. Turkey Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 58. Saudi Arabia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 59. U.A.E Bio-Therapeutic Glycoproteins Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 60. Global Sales Market Share of Bio-Therapeutic Glycoproteins by Type (2018-2029)

    Figure 61. Global Revenue Market Share of Bio-Therapeutic Glycoproteins by Type (2018-2029)

    Figure 62. Global Bio-Therapeutic Glycoproteins Price (USD/Unit) by Type (2018-2029)

    Figure 63. Global Sales Market Share of Bio-Therapeutic Glycoproteins by Application (2018-2029)

    Figure 64. Global Revenue Market Share of Bio-Therapeutic Glycoproteins by Application (2018-2029)

    Figure 65. Global Bio-Therapeutic Glycoproteins Price (USD/Unit) by Application (2018-2029)

    Figure 66. Bio-Therapeutic Glycoproteins Value Chain

    Figure 67. Bio-Therapeutic Glycoproteins Production Process

    Figure 68. Channels of Distribution (Direct Vs Distribution)

    Figure 69. Distributors Profiles

    Figure 70. Bottom-up and Top-down Approaches for This Report

    Figure 71. Data Triangulation

    Figure 72. Key Executives Interviewed